ERBB2 and triple-negative breast carcinoma: In contrast, both MDA-MB468 and MDA-MB231 derive from triple-negative breast cancers, lacking ER-α, PR, and HER-2 expression, and they belong to the basal A and basal B groups, respectively, based on GE profiling.